Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Combinations of a HCV inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent

US Patent 9198907 · Granted Dec 1, 2015

Estimated economic value: $16,590,000

Assignee

Inventors

View full patent text on Google Patents →